4 – CASH FLOW INFORMATION

​

For the six months ended June 30, 2026, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $973 for the Purchase of vessels and ballast water treatment systems, including deposits, $191 for the Purchase of other fixed assets and $35 for the Net proceeds from sale of vessels. For the six months ended June 30, 2026, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $1,988 for Cash dividends payable.

​

For the six months ended June 30, 2025, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $1,631 for the Purchase of vessels and ballast water treatment systems, including deposits, and $119 for the Purchase of other fixed assets. For the six months ended June 30, 2025, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $1,571 for Cash dividends payable and $182 for the Payment of deferred financing costs.

​

During the six months ended June 30, 2026 and 2025, cash paid for interest was $8,998 and $4,130, respectively.

​

During the six months ended June 30, 2026 and 2025, any cash paid for income taxes was insignificant.

​

During the six months ended June 30, 2026, $265,000 of debt outstanding under the $600 Million Revolver was transferred to the $680 Million Revolver. As part of the debt modification, $4,287 was settled net amongst the lenders, which has been included as proceeds from the $680 Million Revolver and repayments on the $600 Million Revolver. Refer Note 8 — Debt for further information.

​

All stock options exercised during the six months ended June 30, 2026 and 2025 were cashless. Refer to Note 13 — Stock-Based Compensation for further information.

​

On June 18, 2026, the Company granted 29,779 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $705.

​

On February 16, 2026, the Company granted 210,826 restricted stock units and 118,596 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $4,682 and $3,026, respectively.

​

On May 20, 2025, the Company granted 59,136 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $825.

​

On February 18, 2025, the Company granted 267,344 restricted stock units and 145,792 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $3,970 and $2,479, respectively.

​

Refer to Note 13 — Stock-Based Compensation for further information regarding the aforementioned grants.

​

Supplemental Condensed Consolidated Cash Flow information related to leases is as follows:

​

​